Evidence map›Paper›PMID 36135763›Full record

ArticleMarine drugs2022

Sarcoeleganolides C-G, Five New Cembranes from the South China Sea Soft Coral

Cili Wang, Jiarui Zhang, Xing Shi, Kai Li, Fengling Li, Xuli Tang, Guoqiang Li, Pinglin Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Cili WangKey Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Jiarui ZhangKey Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Xing ShiKey Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Kai LiKey Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Fengling LiBiology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China.
Xuli TangCollege of Chemistry and Chemical Engineering, Ocean University of China, Qingdao 266100, China.
Guoqiang LiKey Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.ORCID 0000-0003-3223-4007
Pinglin LiKey Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Qingdao National Laboratory for Marine Science and Technology · CNOcean University of China · CNQilu University of Technology · CN

Funding

the National Natural Science Foundation of China 41876161the National Natural Science Foundation of China 81991522
6 · The paper itself

Abstract

Five new cembranes, named sarcoeleganolides C-G (

Indexed as

AnthozoaDiterpenesAnimalsChinaIndomethacinMagnetic Resonance SpectroscopyMolecular StructureZebrafishDiterpenesIndomethacinanti-inflammation activitycembranessarcoeleganolides C–GSarcophyton elegans

Identifiers

PMID36135763
PMCPMC9506240
OpenAlexW4295539244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.